We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Ways to Generate Embryonic Stem Cells

By Biotechdaily staff writers
Posted on 23 Oct 2005
Scientists have developed two new methods to generate embryonic stem cells (ESCs) in mice that may quell the objections of those who claim that stem cell research necessitates the destruction of human life. More...
Both methods were described in the October 16, 2005, online edition of Nature.

One method, called altered nuclear transfer (ANT), was developed by scientists at the Massachusetts Institute of Technology and the Whitehead Institute for Biomedical Research (MIT, Cambridge, MA, USA) as an ethical alternative to somatic cell nuclear transfer (SCNT), or therapeutic cloning. This method is similar to SCNT but before the donor nucleus is transferred into the egg cell, its DNA is altered so that the resulting blastocyst has no chance of becoming a viable embryo or human being.

The scientists used RNA interference (RNAi) to shut off a gene called Cdxx2, which enables an embryo to grow a placenta. Once the stem cells had been extracted from the blastocysts, the siRNA molecule was deleted by transferring a plasmid into each cell. Stem cells resulting from this procedure proved to be just as robust and versatile as stem cells procured in the traditional way.

"Our work is the first proof-of-principle study to show that altered nuclear transfer not only works but is extremely efficient,” said lead author Rudolf Jaenisch, professor of biology at MIT.

The second method was developed by researchers at Advanced Cell Technology, Inc. (ATC, Worcester, MA, USA). They used a method of deriving stem cells in mice using a single-cell embryo biopsy similar to a method used in preimplantation genetic diagnosis. This technique does not interfere with the developmental potential of embryos. After implantation into a mouse womb, the embryo survived and developed into a baby mouse. The researchers say this method could be used with human embryos.

"In the past, stem cell lines have been isolated from the inner cell mass of blastocysts and in a few instances, from earlier, cleavage-stage embryos,” noted first autor Young Chung, senior scientist at ATC. "We generated five embryonic stem (ES) cells and seven trophoblast stem (TS) cell lines from single mouse embryo cells. The stem cells were able to generate all the cell types of the body, including nerve cells, bone, and beating heart.”





Related Links:
Whitehead Inst./MIT
Advanced Cell Technology, Inc.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.